皇馬科技(603181.SH):擬增加回購股份金額、上調至1.3億-2.6億元
格隆匯12月26日丨皇馬科技(603181.SH)公佈,公司於2022年12月26日召開第七屆董事會第五次會議審議通過了《關於增加回購股份金額的議案》,根據有關法律法規的相關規定,為積極響應證監會、國資委、全國工商聯聯合發佈《關於進一步支持上市公司健康發展的通知》(證監發[2022]36號),此次董事會決定繼續增加此次回購股份的金額,由第六屆董事會第十五次會議審議通過的擬回購股份資金總額:不低於人民幣0.65億元,不超過人民幣1.3億元。調整為:不低於人民幣1.3億元,不超過人民幣2.6億元。回購方案的其他內容不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.